Home Team/Scientists>
Latest News
See all news



Aurélie Docquier

Aurélie Docquier, PhD, is Doctor of molecular and cellular biology. During her PhD at the INSERM unit 896 within the Institut de Recherche en Cancérologie de Montpellier, she studied the regulation of genes involved in cell cycle progression in breast cancer and the impact of several hormones on estrogen receptors in ovarian cancer. Then, she joined INRA as a postdoc and was then appointed Preclinical Study Director at 4P-Pharma in 2014, a CRO specialized in oncology. Aurélie joined OREGA Biotech as Project leader in 2016 and is based in Montpellier. See Aurélie’s publications.

CĂ©cile DĂ©jou

Cécile is engineer in Biotechnology. She worked at Sysdiag (BioRad/CNRS) within the monoclonal antibody platform from 2008 to 2009 and then worked on immunotherapy for rheumatoid arthritis at INSERM U844 in Montpellier from 2009 to 2013. She joined OREGA Biotech in 2013 as R&D engineer and then Project leader (Montpellier). See Cécile’s publications.

Alexandre Zampieri

Alexandre is engineer in Biochemistry and Biotechnology. He worked at Institu de génomique Fonctionnelle (INSERM) in Montpellier from 2013 to 2016 and then worked at Institut de Cancérologie de Montpellier in 2016 and 2017. He joined OREGA Biotech in 2017 as R&D engineer (Montpellier). See Alexandre's publications.

See all events